Tailored Clopidogrel Loading Dose According to Platelet Reactivity Monitoring to Prevent Acute and Subacute Stent Thrombosis

This publication has 27 references indexed in Scilit:

• Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial
  The Lancet, 2008
• Adjusted Clopidogrel Loading Doses According to Vasodilator-Stimulated Phosphoprotein Phosphorylation Index Decrease Rate of Major Adverse Cardiovascular Events in Patients With Clopidogrel Resistance
  Journal of the American College of Cardiology, 2008
• Drug-Eluting Stent Thrombosis
  Journal of the American College of Cardiology, 2008
• Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation
  European Heart Journal, 2008
• Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
  New England Journal of Medicine, 2007
• ADP-induced platelet aggregation and platelet reactivity index VASP are good predictive markers for clinical outcomes in non-ST elevation acute coronary syndrome
  Thrombosis and Haemostasis, 2007
• The significance of vasodilator-stimulated phosphoprotein for risk stratification of stent thrombosis
  Thrombosis and Haemostasis, 2007
• Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation
  European Heart Journal, 2006
• Clopidogrel Resistance Is Associated With Increased Risk of Recurrent Atherothrombotic Events in Patients With Acute Myocardial Infarction
  Circulation, 2004
• Subacute thrombotic complications after intracoronary implantation of Palmaz-Schatz stents
  American Heart Journal, 1993